SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report
SEC Accession No. 0001193125-16-691914
Filing Date
2016-08-25
Accepted
2016-08-25 17:25:56
Documents
11
Period of Report
2016-08-24
Filing Date Changed
2016-08-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d426939d8k.htm 8-K 38194
2 EX-1.1 d426939dex11.htm EX-1.1 50319
3 EX-3.1 d426939dex31.htm EX-3.1 92932
4 EX-4.1 d426939dex41.htm EX-4.1 72745
5 EX-5.1 d426939dex51.htm EX-5.1 20170
6 EX-10.1 d426939dex101.htm EX-10.1 172827
7 EX-23.1 d426939dex231.htm EX-23.1 1937
8 EX-99.1 d426939dex991.htm EX-99.1 11379
9 EX-99.2 d426939dex992.htm EX-99.2 11899
10 GRAPHIC g426939g00j67.jpg GRAPHIC 6939
11 GRAPHIC g426939g49g22.jpg GRAPHIC 5903
  Complete submission text file 0001193125-16-691914.txt   491862
Mailing Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931
Business Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36457 | Film No.: 161852334
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1